Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov
ASTH The article is a Form 8-K filing detailing corporate actions such as director elections, auditor ratification, executive compensation approval, and the approval of an equity incentive plan. It does not contain market-moving news or opinions.

8-K — Astrana Health, Inc.

Accession: 0001104659-26-072343

Filed: 2026-06-10

Period: 2026-06-10

CIK: 0001083446

SIC: 8742 (SERVICES-MANAGEMENT CONSULTING SERVICES)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Submission of Matters to a Vote of Security Holders

Item: Financial Statements and Exhibits

Documents

8-K — tm2614755d1_8k.htm (Primary)

EX-10.1 — EXHIBIT 10.1 (tm2614755d1_ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2614755d1_8k.htm · Sequence: 1

false

0001083446

0001083446

2026-06-10

2026-06-10

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,

DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the

Securities Exchange Act of 1934

Date of report (Date of earliest event

reported): June 10, 2026

ASTRANA HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware

001-37392

95-4472349

(State or Other Jurisdiction

(Commission

(I.R.S. Employer

of Incorporation)

File Number)

Identification No.)

1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801

(Address of Principal Executive Offices) (Zip Code)

(626) 282-0288

Registrant’s Telephone Number, Including

Area Code

(Former Name or Former Address, if Changed Since

Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

symbol(s)

Name

of each exchange on which registered

Common

Stock, $0.001 par value per share

ASTH

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange

Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of

Certain Officers.

The stockholders of Astrana

Health, Inc. (the “Company”) approved the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan

(as amended and restated, the “2024 Plan”) at the 2026 Annual Meeting of Stockholders of the Company (the “Annual Meeting”)

held on June 10, 2026. The 2024 Plan was previously approved by the Company’s Board of Directors (the “Board”).

As amended and restated, the number of shares of the Company’s common stock reserved for issuance under the 2024 Plan has been increased

by 1,000,000 shares, and the term of the 2024 Plan has been extended until March 24, 2036.

A summary of the 2024

Plan is included in Proposal

4 of the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 17,

2026 (the “Proxy Statement”), which summary is incorporated in its entirety herein by reference. The summaries of the 2024

Plan contained herein and in the Proxy Statement do not purport to be complete and are subject to, and qualified in their entirety by

reference to, the full text of the 2024 Plan, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and

is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company held its

Annual Meeting on June 10, 2026. At the close of business on April 14, 2026, the record date for the Annual Meeting (the “Record

Date”), there were 55,713,532 shares of common stock, par value $0.001 per share, of the Company issued and outstanding. At the

Annual Meeting, there were present in person or by proxy 43,772,595 shares of the Company’s common stock, representing stockholders

entitled to cast approximately 78.6% of the total outstanding eligible votes and constituting a quorum. At the Annual Meeting:

1. Nine directors were elected to the Board, each to hold office until the 2027 Annual Meeting of Stockholders.

2. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal

year ending December 31, 2026 was ratified.

3. The compensation program for the Company’s named executive officers as disclosed in Proxy Statement was approved, on an advisory,

non-binding basis.

4. The 2024 Plan was approved.

The voting results for each such matter were

as follows:

Proposal 1. Election of Directors

Nominee

For

Withheld

Broker Non-Votes

Kenneth Sim, M.D.

33,456,519

1,959,958

8,356,118

Thomas S. Lam, M.D., M.P.H.

33,486,509

1,929,968

8,356,118

John Chiang

34,104,046

1,312,431

8,356,118

Weili Dai

33,926,696

1,489,781

8,356,118

Linda Dong

33,330,641

2,085,836

8,356,118

J. Lorraine Estradas, R.N., B.S.N. M.P.H.

32,171,774

3,244,703

8,356,118

Mitchell W. Kitayama

33,320,506

2,095,971

8,356,118

Matthew Mazdyasni

33,610,789

1,805,688

8,356,118

David G. Schmidt

33,198,453

2,218,024

8,356,118

Proposal 2. Ratification of Appointment

of Independent Registered Public Accounting Firm

For

Against

Abstain

Broker Non-Votes

43,722,509

19,566

30,520

—

Proposal 3. Advisory Vote on Executive

Compensation

For

Against

Abstain

Broker Non-Votes

34,119,199

1,209,072

88,206

8,356,118

Proposal 4. Approval of the 2024 Plan

For

Against

Abstain

Broker Non-Votes

34,679,879

701,303

35,295

8,356,118

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

No.

Description of Exhibit

10.1*

Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan.

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

* Management contract or compensatory plan, contract or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ASTRANA HEALTH, INC.

Date: June 10, 2026

By:

/s/ Brandon K. Sim

Name:

Brandon K. Sim

Title:

Chief Executive Officer and President

EX-10.1 — EXHIBIT 10.1

EX-10.1

Filename: tm2614755d1_ex10-1.htm · Sequence: 2

Exhibit 10.1

ASTRANA HEALTH, INC.

AMENDED AND RESTATED 2024 EQUITY INCENTIVE PLAN

1.             Establishment,

Purpose, Duration.

(a)           Establishment;

Amendment and Restatement. Astrana Health, Inc. (the “Company”) originally established the Astrana Health, Inc.

2024 Equity Incentive Plan, effective as of February 28, 2024 (the “Effective Date”), and the Plan was originally

approved by the stockholders of the Company at the 2024 Annual Meeting of Stockholders. The Plan was amended and restated in its entirety

effective as of March 26, 2025, and was most recently approved by the stockholders of the Company at the 2025 Annual Meeting of Stockholders.

The Plan is hereby further amended and restated in its entirety as set forth herein, effective as of March 25, 2026 (the “2026

Restatement Date”), subject to approval of the amended and restated Plan by the stockholders of the Company at the 2026 Annual

Meeting of Stockholders. Definitions of certain capitalized terms used in the Plan are contained in Section 2 hereof.

(b)           Purpose.

The purpose of the Plan is to attract and retain Directors, Consultants, officers and other key Employees of the Company and its Subsidiaries,

and to provide to such persons incentives and rewards for superior performance.

(c)           Duration.

No Award may be granted under the Plan on or after the tenth (10th) anniversary of the 2026 Restatement Date, or such earlier date as

the Board shall determine. The Plan will remain in effect with respect to outstanding Awards until no Awards remain outstanding.

(d)           Termination

of 2015 Plan. The Company’s 2015 Equity Incentive Plan (the “2015 Plan”) terminated in its entirety effective

upon stockholder approval of the Plan, and no further awards may be granted under the 2015 Plan thereafter; provided that all outstanding

awards under the 2015 Plan as of the date of the 2024 Annual Meeting of Stockholders shall remain outstanding and shall be administered

and settled in accordance with their terms and the provisions of the 2015 Plan.

2.             Definitions.

As used in the Plan, the following definitions shall apply.

(a)           “2026

Restatement Date” has the meaning given such term in Section 1(a) hereof.

(b)           “Applicable

Laws” means the applicable requirements relating to the administration of equity-based compensation plans under U.S. state corporate

laws, U.S. federal and state securities laws, the Code, the rules of any stock exchange or quotation system on which the Shares are

listed or quoted and the applicable laws of any other country or jurisdiction where Awards are granted or administered or in which Participants

work or reside.

(c)           “Award”

means an award of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Shares, Restricted Share

Units or Other Share-Based Awards granted pursuant to the terms and conditions of the Plan.

(d)           “Award

Agreement” means either: (i) an agreement, in written or electronic format, entered into by the Company and a Participant

setting forth the terms and provisions applicable to an Award granted under the Plan; or (ii) a statement, in written or electronic

format, issued by the Company to a Participant describing the terms and provisions of such Award, which need not be signed by the Participant.

(e)           “Beneficial

Owner” shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act and any successor to such Rule.

(f)            “Board”

means the Board of Directors of the Company.

(g)           “Cause”

as a reason for the Company’s (or a Subsidiary’s) termination of a Participant’s Continuous Service shall have the meaning

specified in the applicable Award Agreement. In the absence of any definition in the Award Agreement, “Cause” shall

have the equivalent meaning or the same meaning as “cause” or “for cause” set forth in any employment, consulting,

or other agreement for the performance of services between the Participant and the Company or a Subsidiary or, in the absence of any such

agreement that defines the term, “Cause” shall mean: (i) conduct by the Participant constituting a material act

of willful misconduct in connection with the performance of the Participant’s duties that results in loss, damage or injury that

is material to the Company or a Subsidiary; (ii) the commission by the Participant of any felony; (iii) continued, willful and

deliberate non-performance by the Participant of the Participant’s duties to the Company or a Subsidiary (other than by reason of

the Participant’s physical or mental illness, incapacity or disability); (iv) Participant’s material breach of any employment

agreement, consulting agreement or agreement regarding nondisclosure of confidential information that results in loss, damage or injury

that is material to the Company or a Subsidiary; (v) willful failure to cooperate with a bona fide internal investigation or an investigation

by regulatory or law enforcement authorities, after being instructed by the Company or a Subsidiary to cooperate, or the willful destruction

or failure to preserve documents or other materials known to be relevant to such investigation or the willful inducement of others to

fail to cooperate or to produce documents or other materials in connection with such investigations; or (vi) fraud, embezzlement

or theft against the Company or any of its Subsidiaries or affiliates. With respect to the events in (i), (iii) and (iv) herein,

the Company or a Subsidiary shall have delivered written notice to the Participant of its intention to terminate the Participant’s

employment or other service for Cause, which notice specifies in reasonable detail the circumstances claimed to give rise to the Company’s

(or Subsidiary’s) right to terminate the Participant’s employment or other service for Cause and the Participant shall not

have cured such circumstances to the extent such circumstances are reasonably susceptible to cure, as determined by the Company (or Subsidiary)

in good faith, within thirty (30) days following the delivery of such notice to the Participant.

(h)           “Change

of Control” shall mean, unless otherwise specified in an Award Agreement, the occurrence of any of the following:

(i)             Any

Person becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 50% or more of the total voting

power represented by the Company’s then outstanding voting securities (excluding for this purpose any such voting securities held

by the Company or its Subsidiaries or by any employee benefit plan of the Company or a Subsidiary) pursuant to a transaction or a series

of related transactions; or

2

(ii)            The

closing of either (A) A merger or consolidation of the Company whether or not approved by the Board, other than a merger or consolidation

which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining

outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) more than 50% of the

total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation, as the

case may be, outstanding immediately after such merger or consolidation; or (B) the sale or disposition by the Company of all or

substantially all of the Company’s assets; or

(iii)           A

change in the composition of the Board of Directors, as a result of which fewer than a majority of the directors are Incumbent Directors.

For this purpose, “Incumbent Directors” shall mean members of the Board who either (A) are directors of the Company

on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control, or (B) are elected, or

nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such

election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened

proxy contest relating to the election of directors to the Company).

(i)            “Code”

means the Internal Revenue Code of 1986, as amended, and any regulations promulgated and in effect thereunder.

(j)            “Committee”

means the Board’s Compensation Committee or such other committee or subcommittee of the Board as may be duly appointed to administer

the Plan, and having such powers in each instance as shall be specified by the Board. To the extent required by Applicable Laws, the Committee

shall consist of two or more members of the Board, each of whom is a “non-employee director” within the meaning of Rule 16b-3

promulgated under the Exchange Act and an “independent director” within the meaning of applicable rules of any securities

exchange upon which Shares are listed.

(k)           “Company”

means Astrana Health, Inc., a Delaware corporation (formerly known as Apollo Medical Holdings, Inc.), and any successor thereto.

(l)            “Consultant”

means an independent contractor who (i) performs services for the Company or a Subsidiary in a capacity other than as an Employee

or Director, and (ii) qualifies as a consultant under the applicable rules of the SEC for registration of shares on a Form S-8

Registration Statement.

(m)           “Continuous

Service” means the uninterrupted provision of services to the Company or any Subsidiary in any capacity of Employee, Director

or Consultant. Continuous Service shall not be considered to be interrupted in the case of (i) any approved leave of absence; (ii) transfers

among the Company, any Subsidiaries, or any successor entities, in any capacity of Employee, Director or Consultant; or (iii) any

change in status as long as the individual remains in the service of the Company, a Subsidiary, or successor of either in any capacity

of Employee, Director or Consultant (except as otherwise provided in such individual’s Award Agreement). An approved leave of absence

shall include sick leave, military leave, or any other authorized personal leave.

3

(n)           “Date

of Grant” means the date specified by the Committee on which the grant of an Award is to be effective. The Date of Grant shall

not be earlier than the date of the resolution and action therein by the Committee to grant such Award. In no event shall the Date of

Grant be earlier than the Effective Date.

(o)           “Director”

means any individual who is a member of the Board and who is not an Employee.

(p)           “Effective

Date” has the meaning given such term in Section 1(a) hereof.

(q)           “Employee”

means any employee of the Company or a Subsidiary; provided, however, that for purposes of determining whether any person may be a Participant

for purposes of any grant of Incentive Stock Options, the term “Employee” has the meaning given to such term in Section 3401(c) of

the Code, as interpreted by the regulations thereunder and Applicable Laws.

(r)           “Exchange

Act” means the Securities Exchange Act of 1934 and the rules and regulations promulgated and in effect thereunder, as such

law, rules and regulations may be amended from time to time.

(s)           “Fair

Market Value” means the value of one Share on any relevant date, determined under the following rules: (i) the closing

sale price per Share on that date as reported on the Nasdaq Stock Market or such other principal exchange on which Shares are then trading,

if any, or if there are no sales on that date, on the next preceding trading day during which a sale occurred; (ii) if the Shares

are not reported on a principal exchange or national market system, the average of the closing bid and asked prices last quoted on that

date by an established quotation service for over-the-counter securities; or (iii) if neither (i) nor (ii) applies, (A) with

respect to Stock Options, Stock Appreciation Rights and any Award of stock rights that is subject to Section 409A of the Code, the

value as determined by the Committee through the reasonable application of a reasonable valuation method, taking into account all information

material to the value of the Company, within the meaning of Section 409A of the Code, and (B) with respect to all other Awards,

the fair market value as determined by the Committee in good faith.

(t)           “Good

Reason” shall, with respect to any Participant, have the meaning (if any) specified in the applicable Award Agreement, or, in

the absence of any definition in the Award Agreement, “Good Reason” shall have the equivalent meaning or the same meaning

(if any) as “good reason” or “for good reason” set forth in an applicable employment, consulting or other agreement

for the performance of services between the Participant and the Company or a Subsidiary, if any, that defines such term. For purposes

of clarity, a Participant shall have no rights under this Plan with respect to termination for “Good Reason” unless and to

the extent that such Participant is a party to an applicable Award Agreement, employment agreement, consulting agreement or other agreement

for the performance of services between the Participant and the Company or a Subsidiary that defines the term “Good Reason”

with respect to such Participant.

4

(u)           “Incentive

Stock Option” or “ISO” means a Stock Option that is designated as an Incentive Stock Option and that is intended

to meet the requirements of Section 422 of the Code.

(v)           “Nonqualified

Stock Option” means a Stock Option that is not intended to meet the requirements of Section 422 of the Code or otherwise

does not meet such requirements.

(w)           “Other

Share-Based Award” means an equity-based or equity-related Award not otherwise described by the terms of the Plan, granted in

accordance with the terms and conditions set forth in Section 10 hereof.

(x)           “Participant”

means any eligible individual as set forth in Section 5 who holds one or more outstanding Awards.

(y)           “Performance

Award” has the meaning given such term in Section 14(a).

(z)           “Performance

Objectives” means the performance objective or objectives that may be established by the Committee with respect to an Award

granted pursuant to the Plan. Any Performance Objectives may relate to the performance of the Company or one or more of its Subsidiaries,

divisions, departments, units, functions, partnerships, joint ventures or minority investments, product lines or products, or the performance

of the individual Participant, and may include, without limitation, the Performance Objectives listed in Section 14(a). The Performance

Objectives may be made relative to the performance of a group of comparable companies, or a published or special index that the Committee,

in its sole discretion, deems appropriate, or the Company may select Performance Objectives as compared to various stock market indices.

Performance Objectives may be stated as a combination of such factors. Any Performance Objectives that are financial metrics may be determined

in accordance with United States Generally Accepted Accounting Principles (“GAAP”), if applicable, or may be adjusted

when established to include or exclude any items otherwise includable or excludable under GAAP.

(aa)         “Person”

shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof,

and shall include a “group” as defined in Section 13(d) thereof.

(bb)         “Plan”

means this Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan, as amended from time to time.

(cc)         “Qualified

Termination” means any termination of a Participant’s Continuous Service during the two-year period commencing on the

date of a Change of Control (i) by the Company, any of its Subsidiaries or the entity resulting from such Change of Control other

than for Cause (and not as a result of the Participant’s disability or death), or (ii) if applicable, by the Participant for

Good Reason.

5

(dd)         “Restricted

Shares” means Shares granted or sold pursuant to Section 8 hereof as to which neither the substantial risk of forfeiture

nor the prohibition on transfers referred to in such Section 8 has expired.

(ee)         “Restricted

Share Unit” means a grant or sale of the right to receive Shares or cash at the end of a specified restricted period made pursuant

to Section 9 hereof.

(ff)           “SEC”

means the United States Securities and Exchange Commission, or any successor thereto.

(gg)         “Share”

means a share of common stock of the Company, par value $0.001 per share, or any security into which such Share may be changed by reason

of any transaction or event of the type referred to in Section 16 hereof.

(hh)         “Stock

Appreciation Right” means a right granted pursuant to Section 7.

(ii)           “Stock

Option” means a right to purchase a Share granted to a Participant under the Plan in accordance with the terms and conditions

set forth in Section 6 hereof. Stock Options may be either Incentive Stock Options or Nonqualified Stock Options.

(jj)            “Subsidiary”

means: (i) with respect to an Incentive Stock Option, a “subsidiary corporation” as defined under Section 424(f) of

the Code; and (ii) for all other purposes under the Plan, any corporation or other entity in which the Company owns, directly or

indirectly, a proprietary interest of more than fifty percent (50%) by reason of stock ownership or otherwise.

(kk)         “Substitute

Award” means an Award that is granted in assumption of, or in substitution or exchange for, an outstanding award previously

granted by an entity acquired directly or indirectly by the Company or with which the Company directly or indirectly combines.

(ll)            “Ten

Percent Stockholder” shall mean any Participant who owns more than 10% of the combined voting power of all classes of stock

of the Company, within the meaning of Section 422 of the Code.

(mm)       “2015

Plan” has the meaning given such term in Section 1(d) hereof.

3.           Shares

Available Under the Plan.

(a)           Shares

Available for Awards. The maximum number of Shares that may be granted pursuant to Awards under the Plan shall be 5,100,000 Shares,

all of which may be issued pursuant to Incentive Stock Options. Shares issued or delivered pursuant to an Award may be authorized but

unissued Shares, treasury Shares, including Shares purchased in the open market, or a combination of the foregoing. The aggregate number

of Shares available for issuance or delivery under the Plan shall be subject to adjustment as provided in Section 16 hereof.

6

(b)           Share

Counting. Except as provided in Section 3(c) hereof, the following Shares shall not count against, or shall be added back

to, the Share limit in Section 3(a) hereof: (i) Shares covered by an Award that expires or is forfeited, canceled, surrendered,

or otherwise terminated; (ii) Shares covered by an award granted under the Prior Plan that, after stockholder approval of the Plan,

is forfeited, canceled, surrendered, or otherwise terminated; (iii) Shares covered by an Award that is settled only in cash; and

(iv) Substitute Awards (except as may be required by reason of the rules and regulations of any stock exchange or other trading

market on which the Shares are listed). This Section 3(b) shall apply to the number of Shares reserved and available for Incentive

Stock Options only to the extent consistent with applicable Code provisions relating to Incentive Stock Options under the Code.

(c)           Prohibition

of Liberal Share Recycling. Notwithstanding Section 3(b), the following Shares subject to an Award shall not again be available

for grant as described above, regardless of whether those Shares are actually issued or delivered to the Participant: (i) Shares

tendered in payment of the exercise price of a Stock Option; (ii) Shares withheld by the Company or any Subsidiary to satisfy a tax

withholding obligation with respect to an Award; and (iii) Shares that are repurchased by the Company with Stock Option proceeds.

Without limiting the foregoing, with respect to any Stock Appreciation Right that is settled in Shares, the full number of Shares subject

to the Award shall count against the number of Shares available for Awards under the Plan regardless of the number of Shares used to settle

the Stock Appreciation Right upon exercise.

(d)           Limits

on Awards to Certain Directors. Notwithstanding any other provision of the Plan to the contrary and except as otherwise provided in

this Section 3(d), the aggregate grant date fair value (determined as of the Date of Grant in accordance with FASB ASC Topic 718)

of all Awards granted to any Director (other than any Chair or Vice Chair of the Board) during any single fiscal year, together with any

cash compensation earned by such Director during such fiscal year, shall not exceed seven hundred fifty thousand dollars ($750,000). For

purposes of clarity, the limit set forth in this Section 3(d) shall not apply to the compensation of any Chair or Vice Chair

of the Board.

4.             Administration

of the Plan.

(a)           In

General. The Plan shall be administered by the Committee. Except as otherwise provided by the Board, the Committee shall have full

and final authority in its discretion to take all actions determined by the Committee to be necessary in the administration of the Plan,

including, without limitation, discretion to: (i) select Award recipients; (ii) determine the sizes and types of Awards; (iii) determine

the terms and conditions of Awards in a manner consistent with the Plan; (iv) grant waivers of terms, conditions, restrictions and

limitations applicable to any Award, or (v) accelerate the vesting or exercisability of any Award, in a manner consistent with the

Plan; (vi) construe and interpret the Plan and any Award Agreement or other agreement or instrument entered into under the Plan;

(vii) establish, amend, or waive rules and regulations for the Plan’s administration; and (viii) take such other

action, not inconsistent with the terms of the Plan, as the Committee deems appropriate. To the extent permitted by Applicable Laws, the

Committee may, in its discretion, delegate to one or more Directors or Employees any of the Committee’s authority under the Plan.

The acts of any such delegates shall be treated hereunder as acts of the Committee with respect to any matters so delegated.

7

(b)           Determinations.

The Committee shall have no obligation to treat Participants or eligible Employees, Directors and Consultants uniformly, and the Committee

may make determinations under the Plan selectively among Participants who receive, or Employees, Directors or Consultants who are eligible

to receive, Awards (whether or not such Participants or eligible Employees, Directors or Consultants are similarly situated). All determinations

and decisions made by the Committee pursuant to the provisions of the Plan and all related orders and resolutions of the Committee shall

be final, conclusive and binding on all persons, including the Company, its Subsidiaries, stockholders, Directors, Consultants, Employees,

Participants and their estates and beneficiaries.

(c)           Authority

of the Board. The Board may reserve to itself any or all of the authority or responsibility of the Committee under the Plan or may

act as the administrator of the Plan for any and all purposes. To the extent the Board has reserved any such authority or responsibility,

or during any time that the Board is acting as administrator of the Plan, it shall have all the powers of the Committee hereunder, and

any reference herein to the Committee (other than in this Section 4(c)) shall include the Board. To the extent that any action of

the Board under the Plan conflicts with any action taken by the Committee, the action of the Board shall control. Without limiting the

foregoing, the Board specifically reserves the authority to approve and administer all Awards granted to Directors under the Plan, and

any references in the Plan to the “Committee” with respect to any such Awards shall be deemed to refer to the Board.

5.             Eligibility

and Participation. Each Employee, Director and Consultant is eligible to participate in the Plan, upon selection by the Committee,

in the Committee’s discretion. Subject to the provisions of the Plan, the Committee may, from time to time, select from all eligible

Employees, Directors and Consultants those to whom Awards shall be granted and shall determine, in its sole discretion, the nature of

any and all terms permissible by Applicable Laws and the amount of each Award. No Employee, Director or Consultant shall have the right

to be selected to receive an Award under the Plan, or, having been so selected, to be selected to receive future Awards.

6.             Stock

Options. Subject to the terms and conditions of the Plan, Stock Options may be granted to Participants in such number, and upon such

terms and conditions, as shall be determined by the Committee in its sole discretion.

(a)           Award

Agreement. Each Stock Option shall be evidenced by an Award Agreement that shall specify the exercise price, the term of the Stock

Option, the number of Shares covered by the Stock Option, the conditions upon which the Stock Option shall become vested and exercisable

and such other terms and conditions as the Committee shall determine and which are not inconsistent with the terms and conditions of the

Plan. The Award Agreement also shall specify whether the Stock Option is intended to be an Incentive Stock Option or a Nonqualified Stock

Option. No dividend equivalents may be granted with respect to the Shares underlying a Stock Option.

8

(b)           Exercise

Price. The exercise price per Share of a Stock Option shall be determined by the Committee at the time the Stock Option is granted

and shall be specified in the related Award Agreement; provided, however, that in no event shall the exercise price per

Share of any Stock Option (other than a Substitute Award) be less than one hundred percent (100%) of the Fair Market Value of a Share

on the Date of Grant.

(c)           Term.

The term of a Stock Option shall be determined by the Committee and set forth in the related Award Agreement; provided, however,

that in no event shall the term of any Stock Option exceed ten (10) years from its Date of Grant.

(d)           Exercisability.

Stock Options shall become vested and exercisable at such times and upon such terms and conditions as shall be determined by the Committee

and set forth in the related Award Agreement, subject to the terms and conditions of the Plan, including the minimum vesting provisions

of Section 12 hereof. Such terms and conditions may include, without limitation, the satisfaction of (i) one or more Performance

Objectives, and (ii) time-based vesting requirements.

(e)           Exercise

of Stock Options. Except as otherwise provided in the Plan or in a related Award Agreement, a Stock Option may be exercised for all

or any portion of the Shares for which it is then exercisable. A Stock Option shall be exercised by the delivery of a notice of exercise

to the Company or its designee in a form specified by the Company which sets forth the number of Shares with respect to which the Stock

Option is to be exercised and full payment of the exercise price for such Shares. The exercise price of a Stock Option may be paid, in

the discretion of the Committee and as set forth in the applicable Award Agreement: (i) in cash or its equivalent; (ii) by tendering

(either by actual delivery or attestation) previously acquired Shares having an aggregate Fair Market Value at the time of exercise equal

to the aggregate exercise price; (iii) by a cashless exercise (including by withholding Shares deliverable upon exercise or through

a broker-assisted arrangement to the extent permitted by Applicable Laws); (iv) by a combination of the methods described in the

foregoing clauses (i), (ii) and/or (iii); or (v) through any other method approved by the Committee in its sole discretion.

As soon as practicable after receipt of the notification of exercise and full payment of the exercise price, the Company shall cause the

appropriate number of Shares to be issued to the Participant.

(f)            Special

Rules Applicable to Incentive Stock Options. Notwithstanding any other provision in the Plan to the contrary:

(i)             Incentive

Stock Options may be granted only to Employees. The terms and conditions of Incentive Stock Options shall be subject to and comply with

the requirements of Section 422 of the Code.

(ii)             To

the extent that the aggregate Fair Market Value of the Shares (determined as of the Date of Grant) with respect to which an Incentive

Stock Option is exercisable for the first time by any Participant during any calendar year (under all plans of the Company and its Subsidiaries)

is greater than $100,000 (or such other amount specified in Section 422 of the Code), as calculated under Section 422 of the

Code, then the Stock Option shall be treated as a Nonqualified Stock Option.

9

(iii)           No

Incentive Stock Option shall be granted to any Participant who, on the Date of Grant, is a Ten Percent Stockholder, unless (A) the

exercise price per Share of such Incentive Stock Option is at least one hundred and ten percent (110%) of the Fair Market Value of a Share

on the Date of Grant, and (B) the term of such Incentive Stock Option shall not exceed five (5) years from the Date of Grant.

7.             Stock

Appreciation Rights. Subject to the terms and conditions of the Plan, Stock Appreciation Rights may be granted to Participants in

such number, and upon such terms and conditions, as shall be determined by the Committee in its sole discretion.

(a)           Award

Agreement. Each Stock Appreciation Right shall be evidenced by an Award Agreement that shall specify the exercise price, the term

of the Stock Appreciation Right, the number of Shares covered by the Stock Appreciation Right, the conditions upon which the Stock Appreciation

Right shall become vested and exercisable and such other terms and conditions as the Committee shall determine and which are not inconsistent

with the terms and conditions of the Plan. No dividend equivalents may be granted with respect to the Shares underlying a Stock Appreciation

Right.

(b)           Exercise

Price. The exercise price per Share of a Stock Appreciation Right shall be determined by the Committee at the time the Stock Appreciation

Right is granted and shall be specified in the related Award Agreement; provided, however, that in no event shall the exercise

price per Share of any Stock Appreciation Right (other than a Substitute Award) be less than one hundred percent (100%) of the Fair Market

Value of a Share on the Date of Grant.

(c)           Term.

The term of a Stock Appreciation Right shall be determined by the Committee and set forth in the related Award Agreement; provided,

however, that in no event shall the term of any Stock Appreciation Right exceed ten (10) years from its Date of Grant.

(d)           Exercisability

of Stock Appreciation Rights. A Stock Appreciation Right shall become vested and exercisable at such times and upon such terms and

conditions as may be determined by the Committee and set forth in the related Award Agreement, subject to the terms and conditions of

the Plan, including the minimum vesting provisions of Section 12 hereof. Such terms and conditions may include, without limitation,

the satisfaction of (i) one or more Performance Objectives, and (ii) time-based vesting requirements.

(e)           Exercise

of Stock Appreciation Rights. Except as otherwise provided in the Plan or in a related Award Agreement, a Stock Appreciation Right

may be exercised for all or any portion of the Shares for which it is then exercisable. A Stock Appreciation Right shall be exercised

by the delivery of a notice of exercise to the Company or its designee in a form specified by the Company which sets forth the number

of Shares with respect to which the Stock Appreciation Right is to be exercised. Upon exercise, a Stock Appreciation Right shall entitle

a Participant to an amount equal to (i) the excess of (A) the Fair Market Value of a Share on the exercise date over (B) the

exercise price per Share, multiplied by (ii) the number of Shares with respect to which the Stock Appreciation Right is exercised.

A Stock Appreciation Right may be settled in whole Shares, cash or a combination thereof, as specified by the Committee in the related

Award Agreement.

10

8.             Restricted

Shares. Subject to the terms and conditions of the Plan, Restricted Shares may be granted or sold to Participants in such number,

and upon such terms and conditions, as shall be determined by the Committee in its sole discretion.

(a)           Award

Agreement. Each Restricted Share Award shall be evidenced by an Award Agreement that shall specify the number of Restricted Shares,

the restricted period(s) applicable to the Restricted Shares, the conditions upon which the restrictions on the Restricted Shares

will lapse and such other terms and conditions as the Committee shall determine and which are not inconsistent with the terms and conditions

of the Plan.

(b)           Terms,

Conditions and Restrictions. The Committee shall impose such other terms, conditions and/or restrictions on any Restricted Shares

as it may deem advisable, including, without limitation, a requirement that the Participant pay a purchase price for each Restricted Share,

restrictions based on the achievement of specific Performance Objectives, time-based restrictions or holding requirements or sale restrictions

placed on the Shares by the Company upon vesting of such Restricted Shares subject to the terms and conditions of the Plan, including

the minimum vesting provisions of Section 12 hereof. Unless otherwise provided in the related Award Agreement or required by Applicable

Law, the restrictions imposed on Restricted Shares shall lapse upon the expiration or termination of the applicable restricted period

and the satisfaction of any other applicable terms and conditions.

(c)           Custody

of Certificates. To the extent deemed appropriate by the Committee, the Company may retain any certificates representing Restricted

Shares in the Company’s possession until such time as all terms, conditions and/or restrictions applicable to such Shares have been

satisfied or lapse.

(d)           Rights

Associated with Restricted Shares during Restricted Period. During any restricted period applicable to Restricted Shares: (i) the

Restricted Shares may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated; (ii) unless otherwise provided

in the related Award Agreement, the Participant shall be entitled to exercise any voting rights associated with such Restricted Shares;

and (iii) the Participant shall be entitled to any dividends and other distributions paid with respect to such Restricted Shares

during the restricted period; provided, however, that any dividends with respect to unvested Restricted Shares shall be accumulated

or deemed reinvested in additional Restricted Shares (as determined by the Committee in its sole discretion and set forth in the applicable

Award Agreement), subject to the same terms and conditions as the original Award (including service-based vesting conditions and any Performance

Objectives) until such Award is earned and vested.

9.             Restricted

Share Units. Subject to the terms and conditions of the Plan, Restricted Share Units may be granted or sold to Participants in such

number, and upon such terms and conditions, as shall be determined by the Committee in its sole discretion.

(a)           Award

Agreement. Each Restricted Share Unit Award shall be evidenced by an Award Agreement that shall specify the number of units, the restricted

period(s) applicable to the Restricted Share Units, the conditions upon which the restrictions on the Restricted Share Units will

lapse, the time and method of payment of the Restricted Share Units to the Participant, and such other terms and conditions as the Committee

shall determine and which are not inconsistent with the terms and conditions of the Plan, including the minimum vesting provisions of

Section 12 hereof.

11

(b)           Terms,

Conditions and Restrictions. The Committee shall impose such other terms, conditions and/or restrictions on any Restricted Share Units

as it may deem advisable, including, without limitation, a requirement that the Participant pay a purchase price for each Restricted Share

Unit, restrictions based on the achievement of specific Performance Objectives or time-based restrictions or holding requirements.

(c)           Form of

Settlement. Restricted Share Units may be settled in whole Shares, cash or a combination thereof, as specified by the Committee in

the related Award Agreement.

10.           Other

Share-Based Awards. Subject to the terms and conditions of the Plan, Other Share-Based Awards may be granted to Participants in such

number, and upon such terms and conditions, as shall be determined by the Committee in its sole discretion, subject to the terms and conditions

of the Plan, including the minimum vesting provisions of Section 12 hereof. Other Share-Based Awards are Awards that are valued in

whole or in part by reference to, or otherwise based on the Fair Market Value of, Shares, and shall be in such form as the Committee shall

determine, including without limitation, unrestricted Shares (subject to the limitations of Section 12 hereof) or time-based or performance-based

units that are settled in Shares and/or cash.

(a)           Award

Agreement. Each Other Share-Based Award shall be evidenced by an Award Agreement that shall specify the terms and conditions upon

which the Other Share-Based Award shall become vested, if applicable, the time and method of settlement, the form of settlement and such

other terms and conditions as the Committee shall determine and which are not inconsistent with the terms and conditions of the Plan.

(b)           Form of

Settlement. An Other Share-Based Award may be settled in whole Shares, cash or a combination thereof, as specified by the Committee

in the related Award Agreement.

11.           Dividend

Equivalents. Awards granted under the Plan (other than Stock Options and Stock Appreciation Rights) may provide the Participant with

dividend equivalents, payable on a contingent basis and either in cash or in additional Shares, as determined by the Committee in its

sole discretion and set forth in the related Award Agreement; provided, however, that any dividend equivalents with respect

to an unvested Award shall be either accumulated in cash or deemed reinvested in additional Restricted Share Units, subject to the same

terms and conditions as the original Award (including service-based vesting conditions and the achievement of any Performance Objectives)

until such Award is earned and vested. Notwithstanding anything to the contrary herein, no dividend equivalents may be granted under the

Plan with respect to the Shares underlying any Stock Option or Stock Appreciation Right.

12

12.           Minimum

Vesting Provisions. Notwithstanding any other provision of the Plan to the contrary, Awards granted under the Plan shall not become

vested or exercisable in full any earlier than the first anniversary of the Date of Grant of the Award (excluding, for this purpose, any

(a) Substitute Awards, and (b) Awards to Directors that vest in full no later than the earlier of the first anniversary of the

date of grant or the next annual meeting of stockholders (provided that such vesting period is not less than 50 weeks after the Date of

Grant)); provided, however, that the Committee may grant Awards without regard to the foregoing minimum vesting requirement

with respect to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 3(a) hereof;

and, provided further that the foregoing restriction does not apply to the Committee’s discretion to provide for accelerated

exercisability or vesting of any Award, including in cases of retirement, death, disability, other termination of employment or a Change

of Control, by the terms of the Award Agreement or otherwise. For purposes of clarity, an Award that vests or becomes exercisable in installments

over a period that ends on or after the first anniversary of the Date of Grant of the Award shall be considered to comply with the minimum

vesting provisions of this Section 12.

13.           Compliance

with Section 409A. Awards granted under the Plan shall be designed and administered in such a manner that they are either exempt

from the application of, or comply with, the requirements of Section 409A of the Code. To the extent that the Committee determines

that any award granted under the Plan is subject to Section 409A of the Code, the Award Agreement shall incorporate the terms and

conditions necessary to avoid the imposition of an additional tax under Section 409A of the Code upon a Participant. Notwithstanding

any other provision of the Plan or any Award Agreement (unless the Award Agreement provides otherwise with specific reference to this

Section 13): (a) an Award shall not be granted, deferred, accelerated, extended, paid out, settled, substituted, modified or

adjusted under the Plan in a manner that would result in the imposition of an additional tax under Section 409A of the Code upon

a Participant; and (b) if an Award is subject to Section 409A of the Code, and if the Participant holding the award is a “specified

employee” (as defined in Section 409A of the Code, with such classification to be determined in accordance with the methodology

established by the Company), then, to the extent required to avoid the imposition of an additional tax under Section 409A of the

Code upon a Participant, no distribution or payment of any amount shall be made before the date that is six (6) months following

the date of such Participant’s “separation from service” (as defined in Section 409A of the Code) or, if earlier,

the date of the Participant’s death. Although the Company intends to administer the Plan so that Awards will be exempt from, or

will comply with, the requirements of Section 409A of the Code, the Company does not warrant that any Award under the Plan will qualify

for favorable tax treatment under Section 409A of the Code, or any other provision of federal, state, local, or non-United States

law. The Company shall not be liable to any Participant for any tax, interest, or penalties the Participant might owe as a result of the

grant, holding, vesting, exercise, or payment of any Award under the Plan.

14.           Performance

Objectives.

(a)           In

General. As provided in the Plan, the vesting, exercisability and/or payment of any Award may be conditioned upon the achievement

of one or more Performance Objectives (any such Award, a “Performance Award”). Any Performance Objectives shall be

based on the achievement of one or more criteria selected by the Committee, in its discretion, which may include, but shall not be limited

to, the following: (i) revenue; (ii)  earnings before interest, taxes, depreciation and amortization, as adjusted (EBITDA as

adjusted); (iii) income before income taxes and minority interests; (iv) operating income; (v)  pre- or after-tax income;

(vi) average accounts receivable; (vii)  cash flow; (viii) cash flow per share; (ix) net earnings; (x) basic

or diluted earnings per share; (xi) return on equity; (xii) return on assets; (xiii) return on capital; (xiv) growth

in assets; (xv) economic value added; (xvi) share price performance; (xvii) total stockholder return; (xviii) improvement

or attainment of expense levels; (xix) market share or market penetration; (xx) business expansion, and/or acquisitions or divestitures;

or (xxi) environmental, social or governance metrics.

13

(b)           Establishment

of Performance Objectives. With respect to any Performance Award, the Committee shall establish in writing the Performance Objectives,

the performance period, and any formula for computing the payout of the Performance Awards. Such terms and conditions shall be established

in writing during the first ninety days of the applicable performance period (or by such other date as may be determined by the Committee,

in its discretion).

(c)           Certification

of Performance. Prior to payment, exercise or vesting of any Performance Award, the Committee will certify in writing whether the

applicable Performance Objectives and other material terms imposed on such Performance Award have been satisfied, and, if they have, ascertain

the amount of the payout or vesting of the Performance Award.

(d)           Adjustments.

If the Committee determines that a change in the Company’s business, operations, corporate structure or capital structure, or in

the manner in which it conducts its business, or other events or circumstances render the Performance Objectives unsuitable, the Committee

may, in its discretion and without the consent of any Participant, adjust such Performance Objectives or the related level of achievement,

in whole or in part, as the Committee deems appropriate and equitable, including, without limitation, to exclude the effects of events

that are unusual in nature or infrequent in occurrence (as determined in accordance with applicable financial accounting standards), cumulative

effects of tax or accounting changes, discontinued operations, acquisitions, divestitures and material restructuring or asset impairment

charges.

15.           Transferability.

Except as otherwise determined by the Committee, no Award or dividend equivalents paid with respect to any Award shall be transferable

by the Participant except by will or the laws of descent and distribution; provided, that if so determined by the Committee, each Participant

may, in a manner established by the Board or the Committee, designate a beneficiary to exercise the rights of the Participant with respect

to any Award upon the death of the Participant and to receive Shares or other property issued or delivered under such Award. Except as

otherwise determined by the Committee, Stock Options and Stock Appreciation Rights will be exercisable during a Participant’s lifetime

only by the Participant or, in the event of the Participant’s legal incapacity to do so, by the Participant’s guardian or

legal representative acting on behalf of the Participant in a fiduciary capacity under state law and/or court supervision.

14

16.           Adjustments.

In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting Standards Codification

Topic 718, or any successor thereto), such as a stock dividend, stock split, reverse stock split, spinoff, rights offering, or recapitalization

through a large, nonrecurring cash dividend, the Committee shall cause there to be an equitable adjustment in the number and kind of Shares

specified in Section 3 of the Plan and, with respect to outstanding Awards, in the number and kind of Shares subject to outstanding

Awards and the exercise price or other price of Shares subject to outstanding Awards, in each case to prevent dilution or enlargement

of the rights of Participants. In the event of any other change in corporate capitalization, or in the event of a merger, consolidation,

liquidation, or similar transaction, the Committee may, in its sole discretion, cause there to be an equitable adjustment as described

in the foregoing sentence, to prevent dilution or enlargement of rights; provided, however, that, unless otherwise determined

by the Committee, the number of Shares subject to any Award shall always be rounded down to a whole number. Moreover, in the event of

any such transaction or event, the Committee, in its discretion, may provide in substitution for any or all outstanding Awards such alternative

consideration (including cash) as it, in good faith, may determine to be equitable in the circumstances, and may require in connection

therewith the surrender of all Awards so replaced. Notwithstanding the foregoing, the Committee shall not make any adjustment pursuant

to this Section 16 that would (a) cause any Stock Option intended to qualify as an ISO to fail to so qualify, (b) cause

an Award that is otherwise exempt from Section 409A of the Code to become subject to Section 409A, or (c) cause an Award

that is subject to Section 409A of the Code to fail to satisfy the requirements of Section 409A. The determination of the Committee

as to the foregoing adjustments, if any, shall be conclusive and binding on all Participants and any other persons claiming under or through

any Participant.

17.           Fractional

Shares. The Company shall not be required to issue or deliver any fractional Shares pursuant to the Plan and, unless otherwise provided

by the Committee, fractional shares shall be settled in cash.

18.           Withholding

Taxes. To the extent required by Applicable Laws, a Participant shall be required to satisfy, in a manner satisfactory to the Company

or Subsidiary, as applicable, any withholding tax obligations that arise by reason of the exercise of a Stock Option or Stock Appreciation

Right, the vesting of or settlement of Shares under an Award, an election pursuant to Section 83(b) of the Code or otherwise

with respect to an Award. The Company and its Subsidiaries shall not be required to issue or deliver Shares, make any payment, or recognize

the transfer or disposition of any Shares, until such withholding tax obligations are satisfied. The Committee may permit or require these

obligations to be satisfied by having the Company withhold a portion of the Shares that otherwise would be issued or delivered to a Participant

upon exercise of a Stock Option or Stock Appreciation Right or upon the vesting or settlement of an Award, or by tendering Shares previously

acquired, in each case having a value (as determined by the Company) equal to the amount required to be withheld. Any such elections are

subject to such conditions or procedures as may be established by the Committee and may be subject to disapproval by the Committee. In

no event will the value of the Shares to be withheld or tendered pursuant to this Section 18 to satisfy applicable withholding taxes

exceed the amount of taxes required to be withheld based on the maximum statutory tax rates in the applicable taxing jurisdictions.

19.           Non-U.S.

Participants. Without amending the Plan, the Committee may grant Awards to Participants who are foreign nationals, or who are subject

to Applicable Laws of one or more non-United States jurisdictions, on such terms and conditions different from those specified in the

Plan as may in the judgment of the Committee be necessary or desirable to foster and promote achievement of the purposes of the Plan,

and, in furtherance of such purposes, the Committee may approve such sub-plans, supplements to or amendments, modifications, restatements

or alternative versions of this Plan as may be necessary or advisable to comply with provisions of Applicable Laws of other countries

in which the Company or its Subsidiaries operate or have Employees or Consultants.

15

20.           Compensation

Recovery Policy. Any Award granted to a Participant shall be subject to forfeiture or repayment pursuant to the terms of the Company’s

Compensation Recovery Policy as in effect from time to time (and any similar, supplemental, or successor policy).

21.           Change

of Control.

(a)           In

General. The provisions of this Section 21 shall apply, notwithstanding any other provision of this Plan to the contrary, except

to the extent otherwise specifically provided in a Participant’s Award Agreement.

(b)           Awards

that are Assumed. To the extent outstanding Awards granted under this Plan are assumed, converted or replaced by the resulting entity

in the event of a Change of Control (or, if the Company is the resulting entity in the Change of Control, to the extent such Awards are

continued by the Company), then, except as otherwise provided in the applicable Award Agreement or in another written agreement with the

Participant, or in a Company severance plan applicable to the Participant, or as otherwise determined by the Committee: (i) any outstanding

Awards granted on or after the 2026 Restatement Date that are subject to Performance Objectives shall be converted to service-vesting

awards by the resulting entity, based on the greater of (A) assumed achievement of the Performance Objectives at the “target”

level or (B) actual achievement of the Performance Objectives, as determined by the Committee as of the last day of the Company’s

fiscal quarter ending on or immediately prior to the date of the Change of Control, and such converted service-vesting awards shall continue

to vest based on the Participant’s Continuous Service during the remaining performance period or other period of required service;

(ii) any outstanding Awards granted prior to the 2026 Restatement Date that are subject to Performance Objectives shall be converted

to service-vesting awards by the resulting entity, as if “target” performance had been achieved as of the date of the Change

of Control, and shall continue to vest based on the Participant’s Continuous Service during the remaining performance period or

other period of required service; and (iii) all other Awards shall continue to vest during the applicable vesting period, if any.

Notwithstanding the preceding sentence, if a Participant incurs a Qualified Termination, then upon such termination, all outstanding Awards

shall become fully vested and any such Awards that are Stock Options or Stock Appreciation Rights shall become fully exercisable and shall

remain exercisable for the full duration of their term.

(c)           Awards

that are not Assumed. To the extent outstanding Awards granted under this Plan are not assumed, converted or replaced by the resulting

entity in connection with a Change of Control (or, if the Company is the resulting entity in the Change of Control, to the extent such

Awards are not continued by the Company), then effective immediately prior to the Change of Control, except as otherwise provided in the

applicable Award Agreement or in another written agreement with the Participant, or in a Company severance plan applicable to the Participant,

or as otherwise determined by the Committee: (i) all outstanding Awards held by the Participant that may be exercised shall become

fully exercisable and shall remain exercisable for the full duration of their term; (ii) any specified Performance Objectives with

respect to outstanding Awards granted on or after the 2026 Restatement Date shall be deemed to be satisfied based on the greater of (A) assumed

achievement of the Performance Objectives at the “target” level or (B) actual achievement of the Performance Objectives,

as determined by the Committee as of the last day of the Company’s fiscal quarter ending on or immediately prior to the date of

the Change of Control; (iii) any specified Performance Objectives with respect to outstanding Awards granted prior to the 2026 Restatement

Date shall be deemed to be satisfied at the “target” level; (iv) all other restrictions with respect to outstanding Awards

shall lapse; and (v) all outstanding Awards shall become fully vested.

16

(d)           Cancellation

Right. The Committee may, in its sole discretion and without the consent of Participants, either by the terms of the Award Agreement

applicable to any Award or by resolution adopted prior to the occurrence of the Change of Control, provide that any outstanding Award

(or a portion thereof) shall, upon the occurrence of such Change of Control, be cancelled in exchange for a payment in cash or other property

(including shares of the resulting entity in connection with a Change of Control) in an amount equal to the excess, if any, of the Fair

Market Value of the Shares subject to the Award, over any exercise price related to the Award, which amount may be zero if the Fair Market

Value of a Share on the date of the Change of Control does not exceed the exercise price per Share of the applicable Awards.

22.           Amendment,

Modification and Termination.

(a)           In

General. The Board may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part; provided,

however, that no alteration or amendment that requires stockholder approval in order for the Plan to comply with any rule promulgated

by the SEC or any securities exchange on which Shares are listed or any other Applicable Laws shall be effective unless such amendment

is approved by the requisite vote of stockholders of the Company entitled to vote thereon within the time period required under such applicable

listing standard, rule or law.

(b)           Adjustments

to Outstanding Awards. The Committee may, in its sole discretion and without the consent of any Participant, at any time (i) provide

that all or a portion of a Participant’s Stock Options, Stock Appreciation Rights and other Awards in the nature of rights that

may be exercised shall become fully or partially exercisable; (ii) provide that all or a part of the time-based vesting restrictions

on all or a portion of the outstanding Awards shall lapse, and/or that any Performance Objectives or other performance-based criteria

with respect to any Awards shall be deemed to be wholly or partially satisfied; or (iii) waive any other limitation or requirement

under any such Award, in each case, as of such date as the Committee may, in its sole discretion, declare.

(c)           Prohibition

on Repricing Without Stockholder Approval. Except for adjustments made pursuant to Sections 16 or 21 hereof, the Committee will not,

without the approval of the stockholders of the Company, authorize the amendment of any outstanding Stock Option or Stock Appreciation

Right to reduce the exercise price of such Award. No Stock Option or Stock Appreciation Right will be cancelled and replaced with an Award

having a lower exercise price, or for another Award, or for cash, without approval of the stockholders of the Company, except as provided

in Sections 16 or 21 hereof. Furthermore, no Stock Option or Stock Appreciation Right will provide for the payment, at the time of exercise,

of a cash bonus or grant or sale of another Award without further approval of the stockholders of the Company. This Section 22(c) is

intended to prohibit the repricing of “underwater” Stock Options or Stock Appreciation Rights without stockholder approval

and will not be construed to prohibit the adjustments provided for in Sections 16 or 21 hereof.

17

(d)           Effect

on Outstanding Awards. Notwithstanding any other provision of the Plan to the contrary (other than Sections 14(d), 16, 21, 22(b) and

24(e) hereof, which specifically do not require the consent of Participants), no termination, amendment, suspension, or modification

of the Plan or an Award Agreement shall adversely affect in any material way any Award previously granted under the Plan, without the

written consent of the Participant holding such Award; provided, however, that the Committee may modify an ISO held by a

Participant to disqualify such Stock Option from treatment as an “incentive stock option” under Section 422 of the Code

without the Participant’s consent.

23.           Applicable

Laws. The obligations of the Company with respect to Awards under the Plan shall be subject to all Applicable Laws and such approvals

by any governmental agencies as the Committee determines may be required. The Plan and each Award Agreement shall be governed by the laws

of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation

of the Plan to the substantive law of another jurisdiction.

24.           Miscellaneous.

(a)           Stock

Ownership Guidelines. By accepting any Award under the Plan, each Participant shall thereby agree to comply with the terms and conditions

of any stock ownership guidelines the Company may maintain or establish, as the same may be applicable to the Participant from time to

time, including any applicable stock retention requirements thereunder.

(b)           Deferral

of Awards. Except with respect to Stock Options, Stock Appreciation Rights and Restricted Shares, the Committee, in its discretion,

may permit Participants to elect to defer the issuance or delivery of Shares or the settlement of Awards in cash under the Plan pursuant

to such rules, procedures or programs as it may establish for purposes of the Plan. The Committee also may provide that deferred issuances

and settlements include the payment or crediting of dividend equivalents or interest on the deferral amounts. Any elections and deferrals

permitted under this provision shall comply with Section 409A of the Code, including setting forth the time and manner of the election

(including a compliant time and form of payment), the date on which the election is irrevocable, and whether the election can be changed

until the date it is irrevocable.

(c)           No

Right of Continued Service. The Plan shall not confer upon any Participant any right with respect to continuance of employment or

other service with the Company or any Subsidiary, nor shall it interfere in any way with any right the Company or any Subsidiary would

otherwise have to terminate such Participant’s employment or other service at any time. Awards granted under the Plan shall not

be considered a part of any Participant’s normal or expected compensation or salary for any purposes, including, but not limited

to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards,

pension or retirement or welfare benefits or similar payments, and in no event shall any Award be considered as compensation for, or relating

in any way to, past services for the Company or any Subsidiary or affiliate.

18

(d)           Unfunded,

Unsecured Plan. Neither a Participant nor any other person shall, by reason of participation in the Plan, acquire any right or title

to any assets, funds or property of the Company or any Subsidiary, including without limitation, any specific funds, assets or other property

which the Company or any Subsidiary may set aside in anticipation of any liability under the Plan. A Participant shall have only a contractual

right to an Award or the amounts, if any, payable under the Plan, unsecured by any assets of the Company or any Subsidiary, and nothing

contained in the Plan shall constitute a guarantee that the assets of the Company or any Subsidiary shall be sufficient to pay any benefits

to any person.

(e)           Severability.

If any provision of the Plan or an Award Agreement is or becomes invalid, illegal or unenforceable in any jurisdiction, or would disqualify

the Plan or any Award under any Applicable Law, as determined by the Committee, such provision shall be construed or deemed amended or

limited in scope to conform to such Applicable Law or, in the discretion of the Committee, it shall be stricken and the remainder of the

Plan shall remain in full force and effect.

(f)           Acceptance

of Plan. By accepting any benefit under the Plan, each Participant and each person claiming under or through any such Participant

shall be conclusively deemed to have indicated their acceptance and ratification of, and consent to, all of the terms and conditions of

the Plan, any Award Agreement and any action taken under the Plan by the Committee, the Board or the Company, in any case in accordance

with the terms and conditions of the Plan.

(g)           Successors.

All obligations of the Company under the Plan and with respect to Awards granted hereunder shall be binding on any successor to the Company,

whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or other event, or a sale

or disposition of all or substantially all of the business and/or assets of the Company and references to the “Company” herein

and in any Award Agreements shall be deemed to refer to such successors.

[END OF DOCUMENT]

19

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Jun. 10, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jun. 10, 2026

Entity File Number

001-37392

Entity Registrant Name

ASTRANA HEALTH, INC.

Entity Central Index Key

0001083446

Entity Tax Identification Number

95-4472349

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

1668 S. Garfield Avenue

Entity Address, Address Line Two

2nd Floor

Entity Address, City or Town

Alhambra

Entity Address, State or Province

CA

Entity Address, Postal Zip Code

91801

City Area Code

626

Local Phone Number

282-0288

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, $0.001 par value per share

Trading Symbol

ASTH

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration